{"id":"W2063432158","doi":"10.1007/s10637-011-9719-0","title":"SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma","year":2011,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Sorafenib; Medicine; Internal medicine; Gallbladder; Gastroenterology; Oncology; Carcinoma; Hepatocellular carcinoma; Stage (stratigraphy); Chemotherapy; Gallbladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001685451,0.0002907109,0.0005609201,0.0003222277,0.0001150042,0.00001564245,0.0001319977,0.00004808616,0.0001720808],"category_scores_gemma":[0.00009639157,0.0002113276,0.00005142192,0.0005470364,0.0002140785,0.0002445069,0.0001274822,0.0002025506,0.000004610255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006807921,"about_ca_system_score_gemma":0.0004839834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002359364,"about_ca_topic_score_gemma":0.0006031462,"domain_scores_codex":[0.9980156,0.0000684161,0.0004929614,0.0004605908,0.0006408435,0.0003215578],"domain_scores_gemma":[0.9988922,0.00008556877,0.000177569,0.000314365,0.0002297044,0.0003005452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002773886,0.002649629,0.9667405,0.00009850991,0.0002914624,0.00007534537,0.02529863,0.000003297731,0.00006865727,0.0001309834,0.001018159,0.0008508767],"study_design_scores_gemma":[0.02863069,0.007605258,0.9594144,0.000115214,0.0003039716,0.00001496835,0.002626058,0.00003715655,0.0005756683,0.0003622194,0.00007761538,0.0002367841],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970173,0.0004017659,0.00000635416,0.000265319,0.00005264004,0.001174683,0.00002562849,0.00002853249,0.001027823],"genre_scores_gemma":[0.9972536,0.00000393447,0.001515989,0.000366618,0.00005952253,0.00007606511,0.0000485926,0.00003655688,0.0006391178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0258568,"threshold_uncertainty_score":0.8617691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04928934074195547,"score_gpt":0.2755956105989698,"score_spread":0.2263062698570143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}